SCHEMBL24506818

SCHEMBL24506818

CC(C)(C)c1cc(N)c2ccc(N)nc2n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ ADORA2A P29274 2/20 0.37
▸ ADORA1 P30542 2/20 0.37
▸ HSD17B10 Q99714 1/20 0.36
▸ BACE1 P56817 2/20 0.34
▸ NCK1 P16333 1/20 0.34
▸ GAA P10253 3/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ MITF O75030 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ AGTR1 P30556 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ MCHR1 Q99705 1/20 0.32
▸ NOS3 P29474 1/20 0.31
▸ NOS1 P29475 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24506811 0.86 ALDH1A1 (0.46) KDM4EALDH1A1KMT2AADORA2AADORA1
SCHEMBL24506820 0.74 HSD17B10 (0.39) ALDH1A1HSD17B10
SCHEMBL22521384 0.73 KDM4E (0.43) KDM4EALDH1A1KMT2AHSD17B10BACE1
SCHEMBL11727213 0.69 KDM4E (0.69) KDM4EALDH1A1KMT2AADORA2AADORA1
SCHEMBL24506894 0.68 BACE1 (0.38) KDM4EALDH1A1KMT2AHSD17B10BACE1
SCHEMBL26424915 0.68 MCHR1 (0.44) KDM4EALDH1A1KMT2AHSD17B10LMNA
SCHEMBL24506570 0.68 NR4A2 (0.41) KDM4EALDH1A1KMT2ABACE1NCK1
SCHEMBL11717516 0.67 KDM4E (0.53) KDM4EALDH1A1KMT2AADORA2AADORA1
SCHEMBL24506782 0.67 HSD17B10 (0.35) KDM4EHSD17B10MCHR1NOS3NOS1
SCHEMBL30996188 0.67 ALDH1A1 (1.00) KDM4EALDH1A1KMT2ABACE1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212143-A9 PRMT5 INHIBITOR COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2023-07-06 — — US disclosed
US-20230212143-A9 PRMT5 INHIBITOR COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2023-07-06 — — US disclosed
US-20220185792-A1 PRMT5 INHIBITOR COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2022-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185792-A1 PRMT5 INHIBITOR COMPOUNDS PRMT5, PRMT1, PRMT6 KDM4E 90/4885ALDH1A1 4228/4885KMT2A 61/4885
US-20230212143-A9 PRMT5 INHIBITOR COMPOUNDS PRMT5, PRMT1, PRMT6 KDM4E 90/4885ALDH1A1 4228/4885KMT2A 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback